Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Patterson

Showing results (1071-1080 of 1,501) with videos related to

Pageof 151
Sort By:
Journal of Clinical Immunology|December 4, 2024
Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 DeficiencyXin Zhen, Michael J Betti, Meltem Ece Kars, et al.
Journal of Medicinal Chemistry|September 19, 2019
Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4)Carl A Brooks, Linda S Barton, David J Behm, et al.
Frontiers in Neuroscience|April 16, 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor functionSheila M Fleming, Sophia Scott, Edward J Hamad, et al.
NPJ Parkinson'S Disease|January 3, 2024
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R Patterson, Joseph Kochmanski, Anna C Stoll, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
Improving the developability profile of pyrrolidine progesterone receptor partial agonistsLara S Kallander, David G Washburn, Tram H Hoang, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacementLinda S Barton, James F Callahan, Juan Cantizani, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2025
Mitochondrial fatty acid synthesis and MECR regulate CD4+ T cell function and oxidative metabolismKayLee K Steiner, Arissa C Young, Andrew R Patterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Science Immunology|September 20, 2024
Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammationDarren R Heintzman, Rachael C Sinard, Emilie L Fisher, et al.
Pageof 151

Showing results (1071-1080 of 1,501) with videos related to

Sort By:
Pageof 151
Journal of Clinical Immunology|December 4, 2024
Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 DeficiencyXin Zhen, Michael J Betti, Meltem Ece Kars, et al.
Journal of Medicinal Chemistry|September 19, 2019
Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4)Carl A Brooks, Linda S Barton, David J Behm, et al.
Frontiers in Neuroscience|April 16, 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor functionSheila M Fleming, Sophia Scott, Edward J Hamad, et al.
NPJ Parkinson'S Disease|January 3, 2024
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R Patterson, Joseph Kochmanski, Anna C Stoll, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
Improving the developability profile of pyrrolidine progesterone receptor partial agonistsLara S Kallander, David G Washburn, Tram H Hoang, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacementLinda S Barton, James F Callahan, Juan Cantizani, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2025
Mitochondrial fatty acid synthesis and MECR regulate CD4+ T cell function and oxidative metabolismKayLee K Steiner, Arissa C Young, Andrew R Patterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Science Immunology|September 20, 2024
Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammationDarren R Heintzman, Rachael C Sinard, Emilie L Fisher, et al.
Pageof 151